CABLIVI subst sèche 10 mg c solv flac
7680667920014
CH-66792
B01AX07
06.03.0.
Reimbursement limitations:
CABLIVI.01
Cablivi est remboursé dans le traitement des adultes et des adolescents de 12 ans et …
1 / 3
google
Details
- Product number
- 6679201
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio cryodesiccata: caplacizumabum 10 mg, acidum citricum, natrii citras dihydricus corresp. natrium 1 mg, saccharum, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabile.
Articles (1)
Cablivi 10mg, poudre et solvent pour solution injectable
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.0 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4020.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 66792
- Drug name
- Cablivi, poudre et solvent pour solution injectable
- Galenic form
- PULMIS
- ATC Code
- B01AX07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/10/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 06.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CABLIVI subst sèche 10 mg c solv flac
- Description (DE)
- CABLIVI Trockensub 10 mg c Solv Durchstf
- Market launch
- 01/10/2019
- Narcotic (BTM)
- No